An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project The ProCAncer-I project has completed the first year of its lifecycle at the end of October 2021. With this brief note key results and achievements of the first year are summarized in the sequel....
Within the ProCancer-I project, a total of nine clinical needs will be addressed utilizing artificial intelligence (AI) models trained on ProstateNET – a unified repository of 1.5 million images of prostate MRI acquired across the consortium. In the current landscape...
ProCAncer-I aspires to create the largest interoperable, high-quality multi-parametric Magnetic Resonance Imaging (mpMRI) dataset worldwide/globally comprising more than 11.000 retrospective and more than 6.000 prospective mpMRI examinations, including clinical data,...
Interview with prof. Daniele Regge (Clinical Coordinator of the ProCancer-I project) Q: In the case of prostate cancer there are several tests that can help clinicians in the decision process, for example, prediction algorithms based on PSA blood test and biopsy. Why...
A brief historical survey of European state-of-play, the open issues and the ProCAncer-I approach Over the last decade, Artificial Intelligence (AI) solutions to support the whole value-chain of medical imaging[1] has experienced a considerable acceleration. This...
By the Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF) Champalimaud Foundation (CF) is a private non-profit Portuguese institution, inaugurated in 2010 with the aim of advancing basic and translational world-leading research in...
By the FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE) The FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE) is a Spanish non-profit organization that carries out...
By the Massachusetts General Hospital (The General Hospital Corp) (QTIM) Our lab, the Quantitative Translational Imaging in Medicine (QTIM) lab, at the Athinoula A. Martinos Center for Biomedical Imaging of the Massachusetts General Hospital (MGH), focuses on...
Newsletter #2 Contents
The ProCAncer-I together with the other AI4HI funded projects organised a workshop with the title “Developing open, standard-based, interoperable Cancer Imaging Repositories in Europe: Issues, Experiences and Challenges” within the IEEE BHI-BHS Conference in Ioannina...
The European Researchers' Night is a Europe-wide public event, which displays the diversity of science and its impact on citizens' daily lives. On Saturday, 1st of October 2022, ProCAncer-I was present at the European Researchers Night in Turin. Our researchers...
Really glad to have been a part of the 21st Annual Teaching course at the International Cancer Imaging Society Meeting in Boston! The meeting had the title: "Cancer Imaging: An all-inclusive specialty" and was held on Monday 12th to Wednesday 14th September 2022 at...
PI-CAI (Prostate Imaging: Cancer AI) is an all-new grand challenge organised by various organizations and the Radboud University. The top 5 prostate-AI teams will be invited to join the PI-CAI consortium, and they will be listed as consortium authors on an upcoming...